Journal article
Driving-Related Glucose Patterns Among Older Adults with Type 1 Diabetes
HJ Kwon, S Trawley, S Vogrin, AM Alipoor, PG Colman, S Fourlanos, CA Grills, MH Lee, RJ MacIsaac, DN O'Neal, NA O'Regan, V Sundararajan, GM Ward, SA McAuley
Diabetes Technology and Therapeutics | MARY ANN LIEBERT, INC | Published : 2024
Abstract
Older adults with type 1 diabetes may face challenges driving safely. Glucose “above-5-to-drive” is often recommended for insulin-treated diabetes to minimize hypoglycemia while driving. However, the effectiveness of this recommendation among older adults has not been evaluated. Older drivers with type 1 diabetes were assessed while using sensor-augmented insulin pumps during a 2-week clinical trial run-in. Twenty-three drivers (median age 69 years [interquartile range; IQR 65-72]; diabetes duration 37 years [20-45]) undertook 618 trips (duration 10 min [5-21]). Most trips (n = 535; 87%) were 5.0 mmol/L for 577 trips (93%) and none of these had CGM 90 min and 3 trips >120 min). During 41 tri..
View full abstractRelated Projects (1)
Grants
Awarded by University of Melbourne
Funding Acknowledgements
The ORACL trial was funded by JDRF (3-SRA-2018-667-M-R), the Diabetes Australia Research Program, and St Vincent's Hospital ( Melbourne) Research Endowment Fund. Medtronic supplied discounted insulin pumps and glucose monitoring devices for the study. S.A.M. has been supported by a JDRF Research Award and University of Melbourne Paul Desmond Clinical Research Fellowship. M.H.L. has been supported by a National Health and Medical Research Council (NHMRC) postgraduate scholarship, co-funded by Diabetes Australia. The funders of this study had no role in trial design, data collection, data analysis, data interpretation, or writing of the report.